Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$525M |
| 2 |
Microsoft
MSFT
|
+$520M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$447M |
| 4 |
Intel
INTC
|
+$326M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$312M |
Top Sells
| 1 |
Compañía de Minas Buenaventura
BVN
|
+$320M |
| 2 |
CVS Health
CVS
|
+$165M |
| 3 |
Uber
UBER
|
+$143M |
| 4 |
Invesco KBW Bank ETF
KBWB
|
+$124M |
| 5 |
First Trust NASDAQ Cybersecurity ETF
CIBR
|
+$124M |
Sector Composition
| 1 | Technology | 27.25% |
| 2 | Healthcare | 9.94% |
| 3 | Consumer Discretionary | 9.65% |
| 4 | Financials | 8.41% |
| 5 | Communication Services | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
1101
DELISTED
Sage Therapeutics
SAGE
| $6.31M | ﹤0.01% |
336,473
+212,110
| +171% | +$3.97M |
|
1102
C4 Therapeutics
CCCC
$189M
| $6.3M | ﹤0.01% |
770,728
+635,255
| +469% | +$5.19M |
|
1103
monday.com
MNDY
$9.9B
| $6.24M | ﹤0.01% |
27,617
+8,085
| +41% | +$1.83M |
|
1104
Sun Life Financial
SLF
$33.3B
| $6.2M | ﹤0.01% |
113,541
-27,454
| -19% | -$1.5M |
|
1105
Matador Resources
MTDR
$5.93B
| $6.19M | ﹤0.01% |
92,775
-3,055
| -3% | -$204K |
|
1106
Apogee Therapeutics
APGE
$2.2B
| $6.19M | ﹤0.01% |
93,106
+89,337
| +2,370% | +$5.94M |
|
1107
EastGroup Properties
EGP
$8.9B
| $6.18M | ﹤0.01% |
34,393
+13,755
| +67% | +$2.47M |
|
1108
SS&C Technologies
SSNC
$21.8B
| $6.17M | ﹤0.01% |
95,862
+1,478
| +2% | +$95.1K |
|
1109
Knight Transportation
KNX
$6.77B
| $6.17M | ﹤0.01% |
112,102
+37,586
| +50% | +$2.07M |
|
1110
Associated Banc-Corp
ASB
$4.35B
| $6.14M | ﹤0.01% |
285,217
-20,839
| -7% | -$448K |
|
1111
Ryanair
RYAAY
$31.1B
| $6.12M | ﹤0.01% |
105,140
+25,582
| +32% | +$1.49M |
|
1112
Biomea Fusion
BMEA
$115M
| $6.12M | ﹤0.01% |
409,558
+356,365
| +670% | +$5.33M |
|
1113
Shoals Technologies Group
SHLS
$1.15B
| $6.11M | ﹤0.01% |
546,666
+489,897
| +863% | +$5.48M |
|
1114
Viridian Therapeutics
VRDN
$1.54B
| $6.09M | ﹤0.01% |
347,913
+263,626
| +313% | +$4.62M |
|
1115
Cleveland-Cliffs
CLF
$5.78B
| $6.08M | ﹤0.01% |
267,534
-244,780
| -48% | -$5.57M |
|
1116
UiPath
PATH
$6.1B
| $6.07M | ﹤0.01% |
267,663
+77,897
| +41% | +$1.77M |
|
1117
ImmunityBio
IBRX
$2.46B
| $6.06M | ﹤0.01% |
1,128,446
+816,424
| +262% | +$4.38M |
|
1118
Veracyte
VCYT
$2.43B
| $6.06M | ﹤0.01% |
273,408
+196,832
| +257% | +$4.36M |
|
1119
Fortis
FTS
$24.9B
| $6.06M | ﹤0.01% |
153,237
+44,957
| +42% | +$1.78M |
|
1120
Protagonist Therapeutics
PTGX
$3.66B
| $6.04M | ﹤0.01% |
208,641
+135,938
| +187% | +$3.93M |
|
1121
SPDR S&P Bank ETF
KBE
$1.56B
| $6.03M | ﹤0.01% |
128,043
-15,548
| -11% | -$732K |
|
1122
Taylor Morrison
TMHC
$6.88B
| $6.03M | ﹤0.01% |
96,936
-177
| -0.2% | -$11K |
|
1123
Antero Resources
AR
$10.2B
| $6.02M | ﹤0.01% |
207,627
-464,364
| -69% | -$13.5M |
|
1124
Avidity Biosciences
RNA
$5.76B
| $6.02M | ﹤0.01% |
235,865
+150,263
| +176% | +$3.83M |
|
1125
WIX.com
WIX
$9.56B
| $6M | ﹤0.01% |
43,632
-12,460
| -22% | -$1.71M |
|